Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Sales 2024 * | 15.86B 60.35B | Sales 2025 * | 16.35B 62.19B | Capitalization | 15.01B 57.1B |
---|---|---|---|---|---|
Net income 2024 * | 1.54B 5.85B | Net income 2025 * | 1.44B 5.49B | EV / Sales 2024 * | 1.87 x |
Net Debt 2024 * | 14.62B 55.63B | Net Debt 2025 * | 12.12B 46.11B | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
10.6
x | P/E ratio 2025 * |
9.91
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
Latest transcript on Teva Pharmaceutical Industries Limited
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 19-12-21 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 15-08-31 |
Janet Vergis
BRD | Director/Board Member | 60 | 20-06-08 |
Sol Barer
CHM | Chairman | 76 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |